Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ludlam

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|August 22, 1981
Lactobacilli do not cause frequency and dysuria syndromeW Brumfitt, J M Hamilton-Miller, H Ludlam, et al.
Journal of Medical Economics|December 3, 2015
Budget impact of pasireotide LAR for the treatment of acromegaly, a rare endocrine disorderJ J Zhang, D Nellesen, W H Ludlam, et al.
Clinical and Laboratory Haematology|October 3, 2002
Cost-effective use of liposomal amphotericin BB O'Connell, J I O Craig, R E Marcus, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 1998
Can a single antibiotic policy for the empirical treatment of febrile neutropenic patients be used for all categories of haematology/oncology patient in the same institution?B O'Connell, R Marcus, V Broadbent, et al.
Pituitary|April 6, 2015
Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controlsMichael S Broder, Maureen P Neary, Eunice Chang, et al.
Journal of Medical Economics|March 13, 2014
Budget impact of pasireotide for the treatment of Cushing's disease, a rare endocrine disorder associated with considerable comorbiditiesH L Truong, D Nellesen, W H Ludlam, et al.
Journal of Medical Microbiology|November 1, 1982
Anaerobic periurethral flora of healthy women and women susceptible to urinary-tract infectionI J Rosenstein, H Ludlam, J M Hamilton-Miller, et al.
Expert Review of Endocrinology & Metabolism|February 21, 2019
Pasireotide (SOM230): a novel pituitary-targeted medical therapy for the treatment of patients with Cushing's diseaseKelley J Moloney, Jennifer U Mercado, William H Ludlam, et al.
Journal of Primary Health Care|September 25, 2024
Comfort with having sexual orientation recorded on official databases among a community and online sample of gay and bisexual men in Aotearoa New ZealandA H Ludlam, H Petousis-Harris, B Arroll, et al.
BMC Research Notes|October 11, 2015
Respondent-driven sampling among gay and bisexual men: experiences from a New Zealand pilot studyAdrian H Ludlam, Peter J W Saxton, Nigel P Dickson, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|August 22, 1981
Lactobacilli do not cause frequency and dysuria syndromeW Brumfitt, J M Hamilton-Miller, H Ludlam, et al.
Journal of Medical Economics|December 3, 2015
Budget impact of pasireotide LAR for the treatment of acromegaly, a rare endocrine disorderJ J Zhang, D Nellesen, W H Ludlam, et al.
Clinical and Laboratory Haematology|October 3, 2002
Cost-effective use of liposomal amphotericin BB O'Connell, J I O Craig, R E Marcus, et al.
The Journal of Antimicrobial Chemotherapy|December 16, 1998
Can a single antibiotic policy for the empirical treatment of febrile neutropenic patients be used for all categories of haematology/oncology patient in the same institution?B O'Connell, R Marcus, V Broadbent, et al.
Pituitary|April 6, 2015
Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controlsMichael S Broder, Maureen P Neary, Eunice Chang, et al.
Journal of Medical Economics|March 13, 2014
Budget impact of pasireotide for the treatment of Cushing's disease, a rare endocrine disorder associated with considerable comorbiditiesH L Truong, D Nellesen, W H Ludlam, et al.
Journal of Medical Microbiology|November 1, 1982
Anaerobic periurethral flora of healthy women and women susceptible to urinary-tract infectionI J Rosenstein, H Ludlam, J M Hamilton-Miller, et al.
Expert Review of Endocrinology & Metabolism|February 21, 2019
Pasireotide (SOM230): a novel pituitary-targeted medical therapy for the treatment of patients with Cushing's diseaseKelley J Moloney, Jennifer U Mercado, William H Ludlam, et al.
Journal of Primary Health Care|September 25, 2024
Comfort with having sexual orientation recorded on official databases among a community and online sample of gay and bisexual men in Aotearoa New ZealandA H Ludlam, H Petousis-Harris, B Arroll, et al.
BMC Research Notes|October 11, 2015
Respondent-driven sampling among gay and bisexual men: experiences from a New Zealand pilot studyAdrian H Ludlam, Peter J W Saxton, Nigel P Dickson, et al.
Pageof 8